¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå : ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1801305
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 225 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,030,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,267,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 11,956,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð´Â 2025³â¿¡ 252¾ï ´Þ·¯, 2025³â-2032³âÀÇ ¿¹Ãø ±â°£¿¡ 8.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 434¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ºÐÀÚÁø´ÜÀº À¯ÀüüÀ̳ª ÇÁ·ÎÅ×¿È ÁßÀÇ »ý¹°ÇÐÀû ¸¶Ä¿¸¦ ºÐ¼®ÇÏ¿© Áúº´ÀÇ Áø´Ü°ú ¸ð´ÏÅ͸µ, À§ÇèÀÇ °ËÃâ, °³º° ȯÀÚ¿¡°Ô ÃÖÀûÀÇ Ä¡·á¹ýÀÇ °áÁ¤ µîÀ» ½Ç½ÃÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ ºÐ¾ß´Â Á¤È®¼º, ½Å¼Ó¼º ¹× Ä¡·áÀÇ °³º°È­ °¡´É¼ºÀ¸·Î ÀÎÇØ ÀÓ»ó¿¡¼­ Á¡Á¡ ´õ ÇʼöÀûÀÔ´Ï´Ù. ºÐÀÚÁø´Ü ½ÃÀåÀº PCR, NGS, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Á¦ÀÚ¸® ºÎÇÕ¹ý°ú °°Àº ±â¼úÀ» Æ÷ÇÔÇÏ¿© º´¿ø, Áø´Ü¿¬±¸¼Ò, ¿¬±¸±â°ü, ÀçÅÃÀÇ·áÀÇ ÇöÀå¿¡¼­ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °¨¿°ÁõÀ̳ª ¸¸¼º ÁúȯÀÇ À¯Çà Áõ°¡, ºÐÀÚ ±â¼úÀÇ Áö¼ÓÀûÀÎ Çõ½ÅÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀåÀº COVID-19, HIV, °£¿°, °áÇÙ°ú °°Àº °¨¿° ºÎ´ã Áõ°¡¿Í °°Àº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, °³ÀÎÈ­µÈ ÀÇ·á ¹× Ç¥Àû Ä¡·á°¡ Á߽õǰí Á¤È®ÇÑ ºÐÀÚ °Ë»ç°¡ ÇÊ¿äÇÕ´Ï´Ù. Á¾¾çÇп¡¼­ µ¿¹ÝÁø´ÜÀÇ º¸±Þ°ú ÇÔ²² POC(Point of Care) Áø´ÜÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °Íµµ ¼ö¿ä¸¦ ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÚµ¿È­, ½Ç½Ã°£ PCR, Â÷¼¼´ë ½ÃÄö½ÌÀÇ ±â¼úÀû Áøº¸·Î Áø´Ü È¿À²¼º, ¼Óµµ ¹× °¨µµ°¡ Çâ»óµÇ¾î °Ç°­ °ü¸® ½Ã½ºÅÛ Àü¹Ý ½ÃÀå µµÀÔÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

À¯¸ÁÇÑ ¼ºÀå¿¡µµ ºÒ±¸ÇÏ°í ºÐÀÚÁø´Ü ½ÃÀåÀº ƯÈ÷ Àú¼Òµæ ¹× Áß»êÃþ ±¹°¡¿¡¼­ Àåºñ ¹× °Ë»ç ºñ¿ëÀÌ ³ôÀº µîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½Å±Ô Áø´Ü Åø¿¡ ´ëÇØ¼­´Â »óȯÀÇ Á¦ÇÑÀÌ ÀÖ¾î, Á¢±Ù¼ºÀÌ Á¦Çѵǰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ÀÇ º¹À⼺°ú ½Ã°£ÀÌ ¸¹ÀÌ °É¸®´Â ½ÂÀÎ ÇÁ·Î¼¼½ºµµ ±â¼ú Çõ½Å°ú ½ÃÀå ÁøÀÔÀÇ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦ÇÑµÈ ÀÚ¿ø ȯ°æ¿¡¼­ ¼÷·ÃµÈ °Ë»ç Àü¹®°¡ÀÇ ºÎÁ·°ú ÀÎÇÁ¶óÀÇ Á¦¾àÀº °í±Þ ºÐÀÚÁø´ÜÀÇ Ã¤ÅÃÀ» ¹æÇØÇÕ´Ï´Ù.

½ÃÀå ±âȸ

ºÐÀÚÁø´Ü ½ÃÀåÀº Á¾¾çÇÐ, À¯ÀüÀÚ°Ë»ç, ¾à¸®À¯ÀüüÇÐ, °¨¿°Áõ °ü¸®¿¡ À־ÀÇ ¿ëµµÀÇ È®´ë¿¡ ÀÇÇØ Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ÀΰøÁö´É°ú ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½ºÀÇ ÅëÇÕÀº Áø´Ü Àü¸ÁÀ» ¹Ù²Ù°í ÀÖ½À´Ï´Ù. ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ¿Í ¹Î°£ Çù·Â Áõ°¡´Â ÷´Ü ºÐÀÚ °Ë»çÀÇ Çõ½Å°ú »ó¾÷È­¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ƯÈ÷ ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÁöÃâ Áõ°¡´Â ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» ¿­ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °Ô´Ù°¡, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç¿ëÀÇ ÈÞ´ë¿ëÀ¸·Î »ç¿ëÇϱ⠽¬¿î ºÐÀÚÁø´Ü ŶÀÇ °³¹ß¿¡ ÀÇÇØ µµ½Ã¿¡¼­µµ ¿ø°ÝÁö¿¡¼­µµ ȯÀÚ Äɾ Çõ¸íÀÌ ÀϾ·Á°í Çϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Á¦Ç° À¯Çüº°, Áúȯ ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå °¡°Ý µ¿Ç⠺м®, 2019³â-2032³â

Á¦5Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦6Àå ¼¼°èÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : Áö¿ªº°

Á¦7Àå ºÏ¹ÌÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦8Àå À¯·´ÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦10Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºÐÀÚÁø´Ü ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Molecular Diagnostics Market - Report Scope:

Molecular diagnostics involves the analysis of biological markers in the genome and proteome to diagnose and monitor disease, detect risk, and decide which therapies will work best for individual patients. This segment has become increasingly essential in clinical practice due to its accuracy, speed, and potential for personalization of treatment. The molecular diagnostics market serves hospitals, diagnostic laboratories, research institutes, and homecare settings, encompassing technologies like PCR, NGS, microarrays, and in situ hybridization. Market expansion is being driven by rising demand for early disease detection, increased prevalence of infectious and chronic diseases, and continuous innovations in molecular technologies.

Market Growth Drivers:

The global molecular diagnostics market is propelled by several key factors, including the rising burden of infectious diseases such as COVID-19, HIV, hepatitis, and tuberculosis. Additionally, the growing emphasis on personalized medicine and targeted therapies necessitates accurate molecular testing. The increasing use of point-of-care diagnostics, along with the proliferation of companion diagnostics in oncology, further enhances the demand. Technological advancements in automation, real-time PCR, and next-generation sequencing are improving diagnostic efficiency, speed, and sensitivity, thereby expanding market adoption across healthcare systems.

Market Restraints:

Despite promising growth, the molecular diagnostics market faces certain challenges, such as high cost of instruments and tests, especially in low- and middle-income countries. Reimbursement limitations, particularly for novel diagnostic tools, restrict accessibility. Regulatory complexities and time-consuming approval processes also act as barriers to innovation and market entry. Furthermore, the shortage of skilled laboratory professionals and infrastructure constraints in resource-limited settings hinder the adoption of advanced molecular diagnostics.

Market Opportunities:

The molecular diagnostics market presents significant growth opportunities fueled by expanding applications in oncology, genetic testing, pharmacogenomics, and infectious disease management. The integration of artificial intelligence and bioinformatics for data analysis is transforming the diagnostic landscape. Increasing investments in research and public-private collaborations are promoting innovation and commercialization of cutting-edge molecular tests. Growing awareness about early disease detection and rising healthcare spending, especially in emerging markets, are expected to unlock new avenues for market expansion. Additionally, the development of portable and easy-to-use molecular diagnostic kits for point-of-care testing is set to revolutionize patient care in both urban and remote areas.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

These companies focus on expanding their test portfolios, developing multiplex and syndromic testing panels, and enhancing automation and throughput of diagnostic systems. Collaborations with biotechnology firms, diagnostic labs, and healthcare institutions drive access and adoption. Furthermore, companies are prioritizing regulatory approvals, market expansion in developing economies, and customer-centric strategies to reinforce their global presence.

Key Companies Profiled:

Molecular Diagnostics Market Research Segmentation:

By Product Type:

By Disease Area:

By End-use:

By Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Dynamics

4. Price Trend Analysis, 2019-2032

5. Global Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

6. Global Molecular Diagnostics Market Outlook: Region

7. North America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

8. Europe Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

9. East Asia Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

10. South Asia & Oceania Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

11. Latin America Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

12. Middle East & Africa Molecular Diagnostics Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

13. Competition Landscape

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â